Saliva testing expansion Accurate Diagnostic Labs has played a pivotal role in scaling saliva-based SARS-CoV-2 testing in collaboration with Rutgers and local partners, indicating a strong base in high-volume molecular diagnostics that can be leveraged for future community-wide screening programs.

Public health partnerships Recent collaborations with Middlesex County, RWJBarnabas Health, RUCDR Infinite Biologics, and Rutgers suggest a proven ability to form multi-stakeholder partnerships, creating opportunities to offer turnkey testing services to government, healthcare systems, and large employers.

Broad service capabilities Beyond SARS-CoV-2 testing, the launch of IgG/IgM antibody panels demonstrates flexibility in serology, enabling cross-selling of comprehensive diagnostic offerings to hospitals, clinics, and diagnostic networks seeking end-to-end infectious disease profiling.

Regional scale opportunity Operating from New Jersey with a mid-size employee base positions the company to pursue regional hospital systems and health networks looking for nimble laboratory partners capable of rapid deployment and scalable testing solutions.

Growth through digital The tech stack including WordPress, MySQL, and standard web security shows a lean digital footprint suitable for partner portals, order automation, and data integration opportunities to streamline B2B workflows and improve partner experience.